BioCardia, Inc. — Director's Dealing 2021

Jan 5, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BioCardia, Inc. (BCDA;BCDAW)
CIK: 0000925741
Period of Report: 2020-12-31

Reporting Person: Blank Andrew Scott (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-12-31	Common Stock	A	2800	—	Acquired	137597	Direct
2020-12-31	Common Stock	A	4843	—	Acquired	142440	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	142850	Indirect

Footnotes

F1: The award relates to vested restricted stock units ("RSUs") granted December 31, 2020, each of which represents a contingent right to receive one share of the Issuer's common stock, but for which delivery of common stock will occur the earliest of (i) two years from the date of grant, (ii) the date the director ceases to be a service provider, or (iii) such other date as the administrator determines under the Issuer's 2016 Equity Incentive Plan.

F2: These shares are held by Andy Blank Revocable Living Trust, of which the Reporting Person serves as trustee.